BG105064A - Пептидни антиангиогенни лекарствени средства - Google Patents
Пептидни антиангиогенни лекарствени средстваInfo
- Publication number
- BG105064A BG105064A BG105064A BG10506400A BG105064A BG 105064 A BG105064 A BG 105064A BG 105064 A BG105064 A BG 105064A BG 10506400 A BG10506400 A BG 10506400A BG 105064 A BG105064 A BG 105064A
- Authority
- BG
- Bulgaria
- Prior art keywords
- peptide
- antiangiogenic drugs
- peptide antiangiogenic
- drugs
- acyl
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 239000004037 angiogenesis inhibitor Substances 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Peptides Or Proteins (AREA)
Abstract
Изобретението се отнася до пептиди с формула А0-А1-А2-А3-А4-А5-А6-А7-А8-А9-А10,в която А0 е избран от водород или ацилова група, А10 е хидроксилна група или аминокиселинен амид, и А0, А1, А2, А3, А4,А5, А6, А7, А8 и А9 са аминоацилови остатъци, посочени в описанието.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8374598A | 1998-05-22 | 1998-05-22 | |
US25057499A | 1999-02-16 | 1999-02-16 | |
US27746699A | 1999-03-26 | 1999-03-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
BG105064A true BG105064A (bg) | 2001-08-31 |
BG65065B1 BG65065B1 (bg) | 2007-01-31 |
Family
ID=27374598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG105064A BG65065B1 (bg) | 1998-05-22 | 2000-12-18 | Пептидни антиангиогенни лекарствени средства |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1078002B1 (bg) |
JP (3) | JP3753612B2 (bg) |
KR (1) | KR100447696B1 (bg) |
CN (1) | CN1311796A (bg) |
AR (1) | AR018371A1 (bg) |
AT (1) | ATE396204T1 (bg) |
AU (1) | AU764277B2 (bg) |
BG (1) | BG65065B1 (bg) |
BR (1) | BR9910639A (bg) |
CA (1) | CA2329250C (bg) |
CO (1) | CO5080726A1 (bg) |
CY (1) | CY1109118T1 (bg) |
CZ (1) | CZ299639B6 (bg) |
DE (1) | DE69938782D1 (bg) |
ES (1) | ES2307337T3 (bg) |
HK (1) | HK1037376A1 (bg) |
HU (1) | HUP0102579A3 (bg) |
NO (1) | NO326871B1 (bg) |
NZ (1) | NZ507912A (bg) |
PL (1) | PL200471B1 (bg) |
PT (1) | PT1078002E (bg) |
SI (1) | SI1078002T1 (bg) |
SK (1) | SK286554B6 (bg) |
TR (1) | TR200003442T2 (bg) |
TW (1) | TWI247748B (bg) |
WO (1) | WO1999061476A1 (bg) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6774211B1 (en) | 1998-05-22 | 2004-08-10 | Abbott Laboratories | Peptide antiangiogenic drugs |
US6753310B1 (en) | 1998-10-16 | 2004-06-22 | Otsuka Pharmaceutical Co., Ltd. | Neovascular-specific peptides |
US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
CN1810832B (zh) | 1998-10-23 | 2012-12-12 | 麒麟-安姆根有限公司 | 与MPl受体结合并具有血小板生成活性的模拟二聚体血小板生成素肽 |
US20020183242A1 (en) * | 2001-04-11 | 2002-12-05 | Jack Henkin | Peptide antiangiogenic drugs |
US20030050246A1 (en) * | 2001-07-26 | 2003-03-13 | Fortuna Haviv | Peptides having antiangiogenic activity |
US7169888B2 (en) | 2001-10-31 | 2007-01-30 | Abbott Laboratories | Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
US20030105025A1 (en) * | 2001-10-31 | 2003-06-05 | Fortuna Haviv | Tri-and tetrapeptides having antiangiogenic activity |
US7001984B2 (en) | 2001-10-31 | 2006-02-21 | Abbott Laboratories | Di-, tri-, and tetra-peptides having antiangiogenic activity |
US7037897B2 (en) | 2001-10-31 | 2006-05-02 | Abbott Laboratories | TRI-, TETRA-, and penta-peptides having antiangiogenic activity |
US20030125260A1 (en) * | 2001-10-31 | 2003-07-03 | Fortuna Haviv | Tetra-and pentapeptides having antiangiogenic activity |
US7067490B2 (en) | 2001-10-31 | 2006-06-27 | Abbott Laboratories | Hepta-, Octa-and nonapeptides having antiangiogenic activity |
US20030125259A1 (en) | 2001-10-31 | 2003-07-03 | Fortuna Haviv | Octa- and nonapeptides having antiangiogenic activity |
MXPA04004135A (es) * | 2001-10-31 | 2004-07-08 | Abbott Lab | Tetra-, penta-, hexa y heptapeptidos con actividad antiangiogenica. |
PL374238A1 (en) * | 2001-10-31 | 2005-10-03 | Abbott Laboratories | Hepta-, octa- and nonapeptides having antiangiogenic activity |
US20030119746A1 (en) * | 2001-10-31 | 2003-06-26 | Fortuna Haviv | Hepta-and octapeptides having antiangiogenic activity |
US7122625B2 (en) | 2001-10-31 | 2006-10-17 | Abbott Laboratories | Hexa-, hepta-, and octapeptides having antiangiogenic activity |
BR0308654A (pt) | 2002-03-22 | 2005-02-22 | Gpc Biotech Ag | Compostos imunossupressores, métodos e usos relacionados a eles |
US7432245B2 (en) | 2002-06-07 | 2008-10-07 | Abbott Laboratories Inc. | Pharmaceutical formulation comprising a peptide angiogenesis inhibitor |
US20030228365A1 (en) * | 2002-06-07 | 2003-12-11 | Fortuna Haviv | Pharmaceutical formulation |
WO2006094269A2 (en) | 2005-03-03 | 2006-09-08 | Covx Technologies Ireland Limited | Anti-angiogenic compounds |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
JP2007255910A (ja) * | 2006-03-20 | 2007-10-04 | Hokkaido Univ | Nmrシグナルの帰属方法 |
JO3324B1 (ar) | 2006-04-21 | 2019-03-13 | Amgen Inc | مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية |
WO2008003013A2 (en) * | 2006-06-29 | 2008-01-03 | Abbott Laboratories | Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic |
CN104004057B (zh) * | 2013-02-25 | 2016-08-24 | 上海市第一人民医院 | 一类抑制新生血管的小肽及其应用 |
CN107778355B (zh) * | 2016-08-25 | 2021-04-20 | 成都圣诺生物制药有限公司 | 一种合成西曲瑞克的方法 |
WO2023033016A1 (ja) * | 2021-09-01 | 2023-03-09 | 積水メディカル株式会社 | アルギニン誘導体 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200397A (en) * | 1990-02-22 | 1993-04-06 | W. R. Grace & Co.-Conn. | Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity |
WO1993016716A1 (en) * | 1992-02-24 | 1993-09-02 | Northwestern University | Method and composition for inhibiting angiogenesis |
JP4426650B2 (ja) * | 1996-05-03 | 2010-03-03 | アボット・ラボラトリーズ | 新規な抗血管形成ペプチド、それをコードするポリヌクレオチド、および血管形成を阻害する方法 |
ATE280781T1 (de) * | 1997-03-17 | 2004-11-15 | Abbott Lab | Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen |
-
1999
- 1999-05-21 DE DE69938782T patent/DE69938782D1/de not_active Expired - Lifetime
- 1999-05-21 ES ES99927091T patent/ES2307337T3/es not_active Expired - Lifetime
- 1999-05-21 CZ CZ20004327A patent/CZ299639B6/cs not_active IP Right Cessation
- 1999-05-21 JP JP2000550879A patent/JP3753612B2/ja not_active Expired - Fee Related
- 1999-05-21 TR TR2000/03442T patent/TR200003442T2/xx unknown
- 1999-05-21 BR BR9910639-6A patent/BR9910639A/pt active Search and Examination
- 1999-05-21 CA CA2329250A patent/CA2329250C/en not_active Expired - Fee Related
- 1999-05-21 CN CN99809104A patent/CN1311796A/zh active Pending
- 1999-05-21 PL PL344415A patent/PL200471B1/pl not_active IP Right Cessation
- 1999-05-21 AT AT99927091T patent/ATE396204T1/de active
- 1999-05-21 SI SI9931014T patent/SI1078002T1/sl unknown
- 1999-05-21 SK SK1763-2000A patent/SK286554B6/sk not_active IP Right Cessation
- 1999-05-21 PT PT99927091T patent/PT1078002E/pt unknown
- 1999-05-21 CO CO99031377A patent/CO5080726A1/es unknown
- 1999-05-21 AU AU44075/99A patent/AU764277B2/en not_active Ceased
- 1999-05-21 AR ARP990102445A patent/AR018371A1/es active IP Right Grant
- 1999-05-21 TW TW088108392A patent/TWI247748B/zh not_active IP Right Cessation
- 1999-05-21 HU HU0102579A patent/HUP0102579A3/hu unknown
- 1999-05-21 KR KR10-2000-7013153A patent/KR100447696B1/ko not_active IP Right Cessation
- 1999-05-21 WO PCT/US1999/011448 patent/WO1999061476A1/en active IP Right Grant
- 1999-05-21 EP EP99927091A patent/EP1078002B1/en not_active Expired - Lifetime
- 1999-05-21 NZ NZ507912A patent/NZ507912A/xx not_active IP Right Cessation
-
2000
- 2000-11-21 NO NO20005890A patent/NO326871B1/no not_active IP Right Cessation
- 2000-12-18 BG BG105064A patent/BG65065B1/bg unknown
-
2001
- 2001-08-24 HK HK01105999A patent/HK1037376A1/xx not_active IP Right Cessation
-
2005
- 2005-05-02 JP JP2005134080A patent/JP3795906B2/ja not_active Expired - Fee Related
-
2006
- 2006-03-10 JP JP2006065255A patent/JP2006232840A/ja active Pending
-
2008
- 2008-07-29 CY CY20081100792T patent/CY1109118T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG105064A (bg) | Пептидни антиангиогенни лекарствени средства | |
TW334418B (en) | Stilbene derivatives and pharmaceutical compositions | |
CA2182158A1 (en) | Detergents and cleaners containing iminodisuccinates | |
NZ298999A (en) | 4-benzyl-5-hydroxyoxazole derivatives acylated in position-1 by an amino acid, a dipeptide or an acyl group | |
EP0765916A3 (en) | Hydrosilylation crosslinkable compositions | |
EP0659715A3 (en) | Gas generating compositions. | |
CA2248110A1 (en) | (hydroxyalkyl)urea crosslinking agents | |
HK1017257A1 (en) | Pharmaceutical composition for immunomodulation based on peptides and adjuvants. | |
EP0662935A4 (en) | GAS GENERATOR. | |
ZA964830B (en) | Amino acid amides of 5-amino-1, 3, 4-thiadizone-2-thiols | |
IL140578A0 (en) | Dolastatin 15 derivatives | |
ZA986358B (en) | Dolastatin 15 derivatives. | |
HUP9801356A3 (en) | Triciclic (2-hydroxy-2-methyl-3,3,3-trifluoropropanoyl)-amino-benzoxepine, -benzothiepine, -benzocycloheptene, -indene derivatives and pharmaceutical compositions containing them | |
HUP0102671A3 (en) | Immunosupressive pharmaceutical compositions containing 2',2'-difluoro-nucleoside analogues | |
EP0577775A4 (en) | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES. | |
HK1009747A1 (en) | New cryptophycins from synthesis. | |
BG103677A (bg) | Твърди смеси на база сулфонилкарбамиди и адюванти | |
IL135723A (en) | 1'-Ä4-Ä1-4-Fluorophenyl)-1H-indole-3-ylÜ-1-butylÜ-spiroÄisobenzofuran-1-(3H),4'-piperidineÜhydrohal ogenides and pharmaceutical compositions containing them | |
EP0921805A4 (en) | PEPTIDES DETECTED BY MELANOMA-SPECIFIC A1, A2 AND A3 RESTRICTED CYTOTOXIC LYMPHOCYTES, AND THEIR USE | |
HUP9900089A3 (en) | Peptide derivatives of dolastatin 15 | |
EP0861817A4 (en) | GAS GENERATING COMPOSITION | |
KR970702796A (ko) | 에어백용 가스발생제 및 이것을 사용한 에어백용 가스발생기(airbag gas-generating agent and airbag gas generator using the same) | |
AU4012795A (en) | Alzheimer's peptide | |
IT1278348B1 (it) | Composizione generatrice di gas "airbag" per autoveicoli. | |
PL314638A1 (en) | Novel ethyloamidofluorenes and pharmaceutic agent |